Биохимические маркеры некроза миокарда
| Вид материала | Документы |
- «Клиническая лабораторная диагностика», 18.81kb.
- Комитета Государственной Думы по здравоохранению Академик рамн колесников С. И. 10., 163.49kb.
- Альтерация, 1013.63kb.
- Биохимические маркеры поражения кости и остеопороза, 95kb.
- Етоды консервативного лечения асептического некроза головки бедренной кости существенно, 45.17kb.
- Результаты хирургического лечения постинфарктных разрывов миокарда левого желудочка, 83.68kb.
- Маркеры неблагоприятного прогноза у больных острым инфарктом миокарда с подъемом сегмента, 647.49kb.
- Ядерный магнитный резонанс в прижизненных исследованиях метаболизма мозга. Метаболические, 12.53kb.
- Новое определение инфаркта миокарда, 621.18kb.
- «Патогенез и лечение инфаркта миокарда с подъёмом сегмента st», 159.75kb.
24. Wallentin L. Invasive compared non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomised multi-centre study. Lancet 1999;354:708—715.
25. La Vecchia L., Finocchi G., Bedogni F. et at. Comparison between Troponin T and Troponin I in the detection of peri procedural myocardial damage after coronary angioplasty. Eur Heart J 1996;Suppl:Abstr:1934.
26. AlpertJ., Thygesen K. Myocardial Infarction Redefined. J Am Coil Cardiol 2000;36:959-969.
27. Teles R., Arrieta L., Ferreira J. et al. Prognostic Influence of Cardiac Troponin I After Coronary Angioplasty. J Am Coil Cardiol 2000;Suppl A:42.
28. Fuchs S., Komowski R., Mehran R. et al. The Deleterious Prognostic Impact of Cardiac Troponin I Re-Elevation Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. J Am Coil Cardiol 2000;35:Suppl A:75.
29. Hamm C., Braunwald E. A classification of unstable angina revisited. Circulation 2000;4:118—122.
30. Heeschen C., Hamm C., Goldman В. et al. Troponin in patients with acute coronary syndromes — are there differences? Eur Heart J 2000;21:Suppl: Abstr: 468.
31. Long K., Schindler S., Folberger C. et al. Discordant results for cardiac troponins in patients with renal failure asymptomatic for ischaemic heart disease. Eur Heart J 1999;20:Suppl:Abstr:396.
32. Haller C., Stevanovich A., Katuis H. Are cardiac troponin reliable serodiagnostic markers of cardiac ischemia in end-stage renal disease9 Nephrol Dial Transplant 1996; 11:941-944.
33. Porter G., Norton Т., Bennett N., Troponin T, a predictor of death in chronic haemodialysis patients. Eur Heart J 1998;19:Suppl N:N34-N37.
34. Godon P., Bonnefoy E., Kircorian G. et al. Serum cardiac Troponin I Increase in Acute Type a Aortic Dissection: A New Independent Predictor of Mortality. J Am Coil Cardiol 2000;35:Suppl A:Abstr: 1091:276.
35 Missov E., Cazolari C., Pau B. Increased Levels of Cardiac Troponin I in Cancer patients. J Am Coil Cardiol 1997:Suppl N:Abstr: 1015.
36. Herman E., ZhangJ., Steven I. et al. Cardiac Troponin T (cTnT) as a Biomarker for Monitoring Chronic Doxorubicin (DXR) Car-diomyopathy. J Am Coil Cardiol 1999;Suppl N:Abstr:1019—1016.
37. Missov E., Calzolari C., Pau B. Cardiac troponin I for early assessment of anthracycline-induced cardiotoxicity. Eur Heart J 1996;Suppl N:Abstr:938.
38. Bonnefoy E., Godon P., Kircorian G. etal. Significance of ST Segment Evaluation in Idiopathic Acute Pericarditis. J Am Coil Cardiol 1999;Suppl N:Abstr:907-904.
39. La Vecchia L., Mezzena G., Varotto L. etal. Detectable serum cardiac troponin I in patients with severe cardiac decompensation of different origin: ckinical correlates and prognostic implications. Eur Heart J 1998;SuppI N:Abstr:925.
40. JaffeA., Ravkilde J., Roberts R. et a/. It's time to change to a troponin standard. Circulation 2000; 12:1216-1220.
41. Katrukha A., Bereyiikova A., Filatov V. et al. Troponin complex for the preparation of troponin I calibratots and standarts. Clin Chem - 1997:43:6:106.
42. Katrukha A., BereuiikovaA., Esakova Т. et al. Troponin I is released in byoodsteram of patients with acute myocardial infarction not in free form but as complex. Clin Chem 1997;43:1379—1385.
43. Katrukha A., Beremikova A., Filatov V. et al. Cardiac troponin I degradation: application for reliable immunodetection. Clin Chem 1998;44:12:2433-2440.
44. Chambless L., Keil U., Dobson A. et al. Population versus clinical view of case fatality from acute coronary heart disease: results from WHO MONICA 1985—1990. Circulation 1997;96:3849-3859.
45. SchuchertA., Hamm C., Schol^J. et al. Prehospital Troponin T Test in Patients With Suspected Acute Myocardial Infarction. J Am Coil Cardiol 1997;Suppl N:Abstr:991-915.
46. Prabani M., Zanninotto M. Diagnostic strategies in myocardial infarction using myoglobin measurement. Eur Heart J 1998; 19:Suppl N:12-15.
47. Drexel H., Dvorak E., Kirchmeir W. et al. Myoglobinemia in early phase of acute myocardial infarction. Am Heart J 1983:105:642— 650.
48. Glatz. J.F., van Bilsen M., Paulussen R. et al. Release of fatty acid-binding prorein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988;961:148-152.
49. Offher G.D.y Brecher P., Sa\vlivich W.B. etal. Characterization and amino acid sequence of a fatty acid-binding protein from human heart. Biochem J 1988;15:252:191-198.
50. Unterberg C., Borchers Т., Hojrup P. et al. Cardiac fatty acid-binding proteins. Isolation and characterization of the mitochondrial fatty acid-binding protein and its structural relationsgip with the cytosolic isoforms. J Biol Chem 1990;25:265:16255-16261.
51. SacchettiniJ.C., Scapin G., Gopaul D., Gordon J.I. Refinement of the structure of Escherichia coli-derived rat intestinal fatty acid binding >protein with bound oleate to 1 75 resolution. Correlation with the structure of tile apoprotein and protein with bound palmitate. J Biol Chem W2;267:23534-23545.
52. Xu Z, Bemlohr 2U., Banasak ZJ. The adipocite lipid-binding protein at 1.6 resolution. J Biol Chem 1993;268:7874~7884.
53. Young А. С., Scapin G., Kromminga A. el al. Structural studies of human muscle fatty acid binding protein at 1.4 A resolution: binding interaction with three С l8 fattyacids. Structure 1994;2:523— 534.
54. Lassen 2)., Lucke С., Kveder M. et al. Three-dimensional structure of bovine heart fatty-acid-binding protein with bound palmitic acid, determined by multidimensional NMR spectroscopy. Eur J Biochem 1995;15:230:266--280.
55. Zanotti G., Scapin G., Spadon P. el al. Three-dimensional structure of recombinant human muscle fatty acid binding protein. J Biol Chem 1992;267:18541-18550.
56. Watanabe K., Wakabayashi H., Veerkamp J. et al. Immunohis-tochemical distribution of heart-type fatty acid-binding protein immunoreactivity in normal human tissues and in myocardial infarction. J Pathol 1993; 170:59-65.
57. Borchers Т., Unterberg С, Buhlmann С., Spener F. Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle ana quantitation with an enzyme-linked immunosorbent assay. Biochim Biophys Acta 1989;14:1002:54—61.
58. Kanda Т., Funjii H. et al. Intestinal fatty acid-binding protein is useful diagnostic marker for mesenteric infarction in humans. Gastroenterology 1996;2.
59. Yoshimoto K., Tanaka Т., Somiya K. et al. Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 1995; 10:304—309.
60. Reisers M., Chapelle J.-P., Knapen M. et al. Influence of age and sex and day-to-day and within-day biological variation of plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 1999;45:3:441-443.
61. Hayashida N., Chihara S. et al. Plasma and urinary levels of healthy acid-binding protein in patients undergoing cardiac surgery. Jpn Circ J 2000; 1:456-459.
62. Wodug K.W., Kragten J.A., Hermens W.T. et al. Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein. Influence of renal function. Eur J Clin Chem 1997;35:191-198.
63. GlafzJ.F., van der Vusse G.J., Simoons M.L. etal. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta 1998:6:272:87-92.
64. Van Bieuwenhoven F.A., Kleine A.H., Wodyg W.H. et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 1995; 15:92:2848—2854.
65. Wu A., Graff-L., Retry G. et al. Role of heart fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 2000;46:4:718-719.
66. Ishii J., Naruse H., Wang J.H. etal. Heart fatty acid-binding protein vs CK-MB in early detection of acute myocardial infarction. J Am Coil Cardiol 1997;29:Suppl: Abstr:451A.
67. Ishii J., Wang J.H., Naruse H. et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997;43:8:Pt 1:1372-1378.
68. Kaptein W., Cheng S., Glatz J. et al. Early detection of acute myocardial infarction with the new marker fatty acid-binding protein: kinetic release and diagnostic value. Eur Heart J 2000;21 :Suppl:Abstr:524.
Источник: /rca_markers1.php